A hypothesis for anti-nanobacteria effects of gallium with observations from treating kidney disease

Medical Hypotheses

Volumn 71, Issue 4, 2008, Pages 584-590

  Eby, George A ^a  

^a George Eby Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; CALCIUM; GALLIUM NITRATE;

ARTICLE; BACTERIUM; CASE REPORT; FEMALE; HUMAN; HYPOTHESIS; KIDNEY DISEASE; NANOBACTERIUM; NEPHROLITHIASIS; PRIORITY JOURNAL; URINALYSIS; URINARY TRACT HEMORRHAGE;

BACTERIA; GALLIUM; HUMANS; KIDNEY CALCULI; MODELS, THEORETICAL;

EID: 50449100767     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.04.025     Document Type: Article

References (35)

1. Kajander E.O., and Çiftçioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA 95 (1998) 8274-8279
2. Ciftcioglu N., Bjorklund M., Kuorikoski K., Bergstrom K., and Kajander E.O. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56 (1999) 1893-1898
3. Ciftcioglu N., Miller-Hjelle M.A., Hjelle J.T., and Kajander E.O. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 46 (2002) 2077-2086
4. Harrington J.R., Martens R.J., Cohen N.D., and Bernstein L.R. Antimicrobial activity of gallium against virulent Rhodococcus equi in vitro and in vivo. J Vet Pharmacol Ther 29 (2006) 121-127
5. Bernstein L.R. Mechanisms of therapeutic activity for gallium. Pharmacol Rev 50 (1998) 665-682
6. Eby G.A. Elimination of arthritis pain and inflammation for over 2 years with a single 90 min, topical 14% gallium nitrate treatment: case reports and review of actions of Gallium-III. Med Hypotheses 65 (2005) 1136-1141
7. Kaneko Y., Thoendel M., Olakanmi O., Britigan B.E., and Singh P.K. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest 117 (2007) 877-888
8. Warrell Jr. R.P. Gallium in the treatment of bone diseases. In: Berthon G. (Ed). Handbook of Metal-Ligand Interactions in Biological Fluids - Bioinorganic Medicine vol. 2 (1995), Marcel Dekker Inc., New York 1253-1265
9. Krakoff I.H., Newman R.A., and Goldberg R.S. Clinical toxicologic and pharmacologic studies of gallium nitrate. Cancer 44 (1979) 1722-1727
10. Cisar J.O., Xu D.Q., Thompson J., Swaim W., Hu L., and Kopecko D.J. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA 97 (2000) 11511-11515
11. Rasmussen T.E., Kirkland B.L., Chalesworth J., et al. Electron microscopic and immunological evidence of nanobacterial-like structures in calcified carotid arteries, aortic aneurysms, and cardiac valves. JACC 39 (2002) 206A (Suppl. 1)
12. Miller V.M., Rodgers G., Charlesworth J.A., Kirkland B., Severson S.R., Rasmussen T.E., Yagubyan M., Rodgers J.C., Cockerill III F.R., Folk R.L., Rzewuska-Lech E., Kumar V., Farell-Baril G., and Lieske J.C. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287 (2004) H1115-H1124
13. Nadra I., Mason J.C., Philippidis P., Florey O., Smythe C.D., McCarthy G.M., Landis R.C., and Haskard D.O. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification. Circ Res 96 (2005) 1248-1256
14. Maniscalco B.S., and Taylor K.A. Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 11 (2004) 95-101
15. Makkonen N., Hirvonen M.R., Savolainen K., Lapinjoki S., and Monkkonen J. The effect of free gallium and gallium in liposomes on cytokine and nitric oxide secretion from macrophage-like cells in vitro. Inflamm Res 44 (1995) 523-528
16. Panagakos F.S., Kumar E., Venescar C., and Guidon P. The effect of gallium nitrate on synoviocyte MMP activity. Biochimie 82 (2000) 147-151
17. Eby G.A. Treatment of acute lymphocytic leukemia using zinc adjuvant with chemotherapy and radiation - a case history and hypothesis. Med Hypotheses 64 (2005) 1124-1126
18. Chua M.S., Bernstein L.R., Li R., and So S.K.S. Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. Anticancer Res 26 (2006) 1739-1743
19. Adamson R.H., Canellos G.P., and Sieber S.M. Studies on the antitumor activity of gallium nitrate (NSC-15200) and other group IIIa metal salts. Cancer Chemother Rep 59 (1975) 599-610
20. Capel I.D., Dorrell H.M., Pinnock M.H., Jenner M., and Williams D.C. The influence of zinc status on the anti-Lewis lung tumour activity of cisplatin and gallium. Anticancer Res 1 (1981) 269-273
21. Jakupec M.A., and Keppler B.K. Gallium in cancer treatment. Curr Top Med Chem 4 (2004) 1575-1583
22. Desoize B. Metals and metal compounds in cancer treatment. Anticancer Res 24 (2004) 1529-1544
23. Collery P., Keppler B., Madoulet C., and Desoize B. Gallium in cancer treatment. Crit Rev Oncol Hematol 42 (2002) 283-296
24. Zhou W., Park S., Liu G., Miller D.P., Wang L.I., Pothier L., Wain J.C., Lynch T.J., Giovannucci E., and Christiani D.C. Dietary iron, zinc, and calcium and the risk of lung cancer. Epidemiology 16 (2005) 772-779
25. Tsurumoto T., Matsumoto T., Yonekura A., and Shindo H. Nanobacteria-like particles in human arthritic synovial fluids. J Proteome Res 5 (2006) 1276-1278
26. Kukowska-Latallo J.F., Candido K.A., Cao Z., Nigavekar S.S., Majoros I.J., Thomas T.P., Balogh L.P., Khan M.K., and Baker Jr. J.R. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65 (2005) 5317-5324
27. Eby G.A., and Eby K.L. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 67 (2006) 362-370
28. Eby GA. Oral gallium nitrate restores soundness in horses with navicular disease - a pilot study. (2008 pending publication) Available at [accessed 16.04.08].
29. Ciftcioglu N., Haddad R.S., Golden D.C., Morrison D.R., and McKay D.S. A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity. Kidney Int 67 (2005) 483-491
30. Eby G.A. Zinc lozenges: cold cure or candy? Solution chemistry determinations. Biosci Rep 24 (2004) 23-39
31. Massey L. Magnesium therapy for nephrolithiasis. Magnes Res 18 (2005) 123-126
32. Belozerov E.S. The content of the trace element gallium in certain foodstuffs (in Russian). Voprosy Pitaniia 25 (1996) 85-86
33. Li Y.-H., Zhao Q.-L., and Huang M.-H. Cathodic adsorptive voltammetry of the gallium-alizarin Red S complex at a carbon paste electrode. Electroanalysis 17 (2005) 343-347
34. McHard J.A., Foulk S.J., and Winefordner J.D. A comparison of trace element contents of Florida and Brazil orange juice. J Agr Food Chem 27 (1979) 1326-1328
35. Eby G.A., and Halcomb W.W. High-dose zinc to terminate angina pectoris: a review and hypothesis for action by ICAM inhibition. Med Hypotheses 66 (2006) 169-172